Complete Remission of Relapsed Hodgkin's Lymphoma following Brentuximab Vedotin and Gemcitabine Combination Therapy with Severe Hypotension as Possible Treatment-Related Adverse Event: A Case Report

A 40-year-old Asian female with heavily treated relapsed Hodgkin's lymphoma showed complete remission (CR) after receiving 8 cycles of brentuximab vedotin (BV) in combination with gemcitabine as 4th line treatment. The patient remained in CR at the 18-month post-treatment follow-up. She develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Purwanto, Ibnu, Utomo, Bambang P., Ghozali, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154270/
https://www.ncbi.nlm.nih.gov/pubmed/32308602
http://dx.doi.org/10.1159/000505830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154270/
https://www.ncbi.nlm.nih.gov/pubmed/32308602
http://dx.doi.org/10.1159/000505830

Ejemplares similares